US › Healthcare

Neuronetics Inc (STIM)

US · Healthcare · Medical Devices

$2.15-11.52%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$42.0M

Revenue YoY

+12.5%

Net profit

$-1.7M

EPS

$-0.02

EPS estimate

$-0.08

Net margin

-4.0%

EPS came in at -0.02 against a street estimate of -0.08 — a beat of 75.0%.

Key statistics

Market cap

$188.9M

Forward P/E

0.0

P/B

9.67

Book value

$0.32

EPS (TTM)

$-0.32

52-week high

$3.44

52-week low

$0.80

50-day MA

$2.49

200-day MA

$1.88

Beta

1.32

Analyst view

Analysts rate Neuronetics Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $5.75.

Shareholding

Insiders

32.87%

Institutions

54.00%

Largest institutional holders

Fund	Stake
Madryn Asset Management, LP	24.33%
UBS Group AG	2.99%
Wexford Capital LP	2.63%
FourWorld Capital Management LLC	2.29%
Lane Generational LLC	2.14%
Vanguard Capital Management, LLC	1.98%
Masters Capital Management LLC	1.31%
AdvisorShares Investments, LLC	0.97%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neuronetics Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.